期刊文献+

抗原诱导关节炎兔关节内注射^(153)钐-柠檬酸-羟基磷灰石的生物学分布及病理学变化 被引量:2

Investigation on the biological distribution and pathological changes of intra-articular injected ^(153) Sm-citrate-hydroxyaptite in antigen-induced arthritis rabbits
暂未订购
导出
摘要 目的 :研究兔关节内注射放射性核素1 53 钐 -柠檬酸 -羟基磷灰石 (1 53 Sm -citrate -HA)制剂的生物学分布及病理学变化。方法 :将 30只新西兰大白兔分为 4组 ,其中 2 4只制作成抗原诱导关节炎 (antigeninducedarthritis,AIA)模型 (AIA兔 )。A组为正常兔 6只 ,B组AIA兔 1 2只 ,2组膝关节腔内注射1 53 Sm -citrate -HA 3.7× 1 0 7Bq后分别于第 3d、第 6d显像 ,用SPECT获得放射性计数并计算核素在关节内滞留率及生物学分布、漏出率。C、D组均为AIA兔 6只 ,C组不做任何治疗 ,D组关节腔内注射1 53 Sm -citrate-HA 3.7× 1 0 7Bq ,2组观察 30d后取滑膜、软骨行病理学观察。结果 :A、B组关节腔内核素的滞留率分别为 (97.7± 1 .2 ) % (3d)、(93.5± 0 .9) % (6d)和 (98.4±1 .4 ) % (3d)、(95 .1± 0 .5 ) % (6d)。关节外漏出率分别为 0 .1 7% (3d)、0 .31 % (6d)和 0 .0 7% (3d)、0 .0 9% (6d)。病理学观察 :D组较C组滑膜炎症明显好转 ,关节软骨未发现损害。结论 :1 53 Sm -citrate-HA漏出率低 ,关节内分布均匀且滞留率高 ,疗效肯定 。 Aim: To study the biological distribution and pathological changes of intra-articular injected 153 Sm-citrate-hydroxyaptite in antigen-induced arthritis rabbits. Methods: Thirty New Zealand rabbits were allocated into four groups. Group A ( n =6) was normal and Group B ( n =12) was AIA (antigen induced arthritis) rabbits. Both groups were injected 153 Sm-citrate-HA 3.7×10 7 Bq in knee joint and were scanned by single ploton emission computed tomography (SPECT) at 3rd and 6th day after injection, then the residual rates in knee joint and bio-distribution were calculated. Group C and D were both AIA rabbits, group C ( n =6) were not treated and group D ( n =6) were injected 153 Sm-citrate-HA 3.7×10 7 Bq in the ill knee joint, then histopathologic changes were observed 30 days later. Results: The intra-articular residual rates were (97.7±1.2)% (3 days), (93.5±0.9)% (6 days) for Group A and (98.4±1.4)% (3 days), (95.1±0.5)% (6 days) for Group B, and the total cumulative extra-articular leakage were 0.17% (3 days), 0.31 % (6 days) for Group A, and 0.07% (3 days) and 0.09% (6 days) for Group B. Histopathologic changes of Group D has been controlled compared with Group C. Conclusion: 153 Sm-citrate-HA radiation therapy is effective and safe with low leakage and high intra-articular residual rates of radioisotope.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2004年第1期74-77,共4页 Journal of Zhengzhou University(Medical Sciences)
关键词 抗原诱导关节炎 ^153钐-柠檬酸-羟基磷灰石 放射性滑膜切除术 病理学 antigen-induced arthritis 153 Sm-citrate-hydroxyaptite radiation synovectomy rabbit pathology
  • 相关文献

参考文献10

  • 1金小海,刘跃民,杜进,王凡,陈大明,白素珍.用于放射性滑膜切除的^(153)Sm-Citrate-HA的制备[J].同位素,1994,7(2):92-97. 被引量:5
  • 2Rittmreister M, Bohme T, Rehart S,et al. Treatment of the ankle joint in rheumatoid arthritis with surgical and radiation synovectomy. Orthopade, 1999,28 (9) : 785.
  • 3Lee P. The efficacy and safety of radiosynovectomy. J Rheumatol,1982, 9(2) :165.
  • 4Steinberg ME, McCrae CR, Berselli RA,et al. Intra-articular 5-fluorouracil in antigen-induced arthritis. J Bone Joint Surg Am,1971,53(3) :514.
  • 5Chinol M, Vallabhajosula S, Goldsmith SJ,et al. Evaluation of four radiopharmaceuticals for imaging inflammation in a rabbit model of arthritis. Ann Nucl Med,1996,10(3):287.
  • 6O'Duffy E K, Oliver F J, Chatters SJ,et al. Chromosomal analysis of peripheral lymphocytes of patients before and after radiation synovectomy with samarium-153 particulate hydroxyapatite. Rheunmtology, 1999,38 (4) :316.
  • 7Chinol M, Vallabhajosula S, Goldsmith SJ, et al. Chemistry and biological behavior of samarium-153 and rhenium-186-labaled hydroxyapatite particles: potential radiopharmaceuticals for radiation synovectomy. J Nucl Med , 1993,34(9):1 536.
  • 8Yarbrough TB, Lee MR, Hornof WJ, et al. Samarium 153labeled hydroxyapatite microspheres for radiation synovectomy in the horse: a study of the biokinetics, dosimetry, clinical, and morphologic response in normal metacarpophalangcal and metatarsophalangeal joints. Vet Surg, 2000,29 (2) :191.
  • 9Noble J,Jones AG, Davis MA, et al. Leakage of radioactive particle systems from a synovial joint studied with a gamma camera. J Bone Joint Surg Am,1983,65(3):384.
  • 10Clunie G, Lui D, Cullum l,et al. Samarium-153-particulate hydroxyapatite radiation synoveetomy: biodistribution data for chronic knee synovitis. J Nuel Med, 1995,36( 1 ) :51.

共引文献4

同被引文献18

  • 1徐琳,谭颖徽,王建华,张纲.失神经支配兔下颌骨骨折愈合过程中CGRP对OPG/RANKL表达的影响[J].第三军医大学学报,2005,27(10):988-990. 被引量:18
  • 2SIMONET W S,LACEY D L,DUNSTAN C R,et al.Osteoprotegerin:a novel secreted protein involved in the regulation of bone density[J].Cell,1997,89(2):309-319.
  • 3YASUDA H,SHIMA N,NAKAGAWA N,et al.Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG):a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro[J].Endocrinology,1998,139(3):1329-1337.
  • 4WONG B R,RHO J,ARRON J,et al.TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-jun N-terminal kinase in T cells[J].J Biol Chem,1997,272(40):25190-25194.
  • 5YASUDA H,SHIMA N,NAKAGAWA N,et al.Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL[J].J Proc Natl Acad Sci USA,1998,95(7):3597-3602.
  • 6LACEY D L,TIMMS E,TAN H L,et al.Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation[J].Cell,1998,93(2):165-176.
  • 7ZHANG Y H,HEULSMANN A,TONDRAVI M M,et al.Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways[J].J Biol Chem,2001,276(1):563-568.
  • 8AZUMA Y,KAJI K,KATOGI R,et al.Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts[J].J Biol Chem,2000,275(7):4858-4864.
  • 9HAYNES D R,POTTER A E,ATKINS G J,et al.Metal particles stimulate expression of regulators of osteoclast development including osteoclast differentiation factor (RANKL/TRANCE),osteoprotegerin macrophage colony stimulating factor[J].Trans Orthop Res Soc,1999,24(3):244-247.
  • 10ITONAGA I,SABOKBAR A,MURRAY D W,et al.Effect of osteoprotegerin and osteoprotegerin ligand on osteoclast formation by arthroplasty membrane derived macrophages[J].Ann Rheum Dis,2000,59(1):26-31.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部